Czech National Bank Buys 955 Shares of McKesson Corporation $MCK

Czech National Bank boosted its position in shares of McKesson Corporation (NYSE:MCK) by 3.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 32,546 shares of the company’s stock after acquiring an additional 955 shares during the period. Czech National Bank’s holdings in McKesson were worth $26,697,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the company. Brighton Jones LLC increased its stake in shares of McKesson by 46.3% in the fourth quarter. Brighton Jones LLC now owns 2,523 shares of the company’s stock worth $1,438,000 after purchasing an additional 798 shares in the last quarter. Caxton Associates LLP bought a new stake in shares of McKesson during the 1st quarter valued at $233,000. Sivia Capital Partners LLC lifted its stake in shares of McKesson by 77.9% during the 2nd quarter. Sivia Capital Partners LLC now owns 685 shares of the company’s stock valued at $502,000 after buying an additional 300 shares in the last quarter. American Century Companies Inc. boosted its holdings in McKesson by 16.0% in the 2nd quarter. American Century Companies Inc. now owns 13,718 shares of the company’s stock worth $10,052,000 after buying an additional 1,895 shares during the period. Finally, Global Retirement Partners LLC bought a new position in McKesson in the 2nd quarter worth $2,319,000. Hedge funds and other institutional investors own 85.07% of the company’s stock.

Insiders Place Their Bets

In other news, EVP Michele Lau sold 2,725 shares of the stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $990.00, for a total transaction of $2,697,750.00. Following the completion of the transaction, the executive vice president directly owned 3,247 shares in the company, valued at approximately $3,214,530. This represents a 45.63% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Maria Martinez sold 349 shares of the firm’s stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $939.87, for a total transaction of $328,014.63. Following the completion of the transaction, the director directly owned 301 shares of the company’s stock, valued at approximately $282,900.87. This trade represents a 53.69% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 3,868 shares of company stock worth $3,743,820. Insiders own 0.08% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on MCK shares. Barclays raised their price target on McKesson from $960.00 to $1,050.00 and gave the company an “overweight” rating in a report on Wednesday, February 18th. JPMorgan Chase & Co. upped their price objective on McKesson from $983.00 to $1,107.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 10th. Evercore reiterated an “outperform” rating on shares of McKesson in a research report on Thursday, March 5th. Morgan Stanley reissued an “overweight” rating and set a $966.00 target price on shares of McKesson in a research note on Thursday, January 29th. Finally, Robert W. Baird set a $968.00 price target on McKesson in a research note on Wednesday, January 14th. Thirteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $960.93.

McKesson Stock Down 0.3%

Shares of MCK stock opened at $879.57 on Thursday. The company’s fifty day simple moving average is $906.79 and its two-hundred day simple moving average is $837.49. McKesson Corporation has a 52 week low of $637.00 and a 52 week high of $999.00. The stock has a market cap of $107.74 billion, a P/E ratio of 25.30, a PEG ratio of 1.42 and a beta of 0.38.

McKesson (NYSE:MCK) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, beating analysts’ consensus estimates of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The firm had revenue of $106.16 billion during the quarter, compared to analyst estimates of $105.98 billion. During the same quarter last year, the business posted $8.03 earnings per share. The business’s quarterly revenue was up 11.4% compared to the same quarter last year. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, analysts anticipate that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd will be issued a dividend of $0.82 per share. This represents a $3.28 annualized dividend and a yield of 0.4%. The ex-dividend date is Monday, March 2nd. McKesson’s dividend payout ratio (DPR) is currently 9.43%.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.